CSX Corporation
CSX
$41.05
+3.22%
CSX Corporation is a Class I railroad operating primarily in the Eastern United States. It is a key player in the rail freight industry, leveraging its extensive network to transport a diverse mix of commodities including coal, chemicals, and intermodal containers.
CSX
CSX Corporation
$41.05
Investment Opinion: Should I buy CSX Today?
Based on a synthesis of the data, the objective assessment for CSX is a Hold. The company's strong operational metrics, cash flow, and market-beating performance are positive, but they are counterbalanced by recent fundamental softness, high valuation multiples, and financial leverage. The forward P/E of 19.1, based on analyst EPS estimates of $2.69, already prices in a recovery, leaving limited near-term upside without clear evidence of accelerating growth. Investors may find better entry points on a more significant pullback.
Sign up to view all
CSX 12-Month Price Forecast
The data presents a mixed picture: strong underlying business quality is offset by near-term growth concerns and a full valuation. The most likely path is range-bound trading around current levels as the company works to meet analyst expectations.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CSX Corporation's 12-month outlook, with a consensus price target around $53.36 and implied upside of +30.0% versus the current price.
Average Target
$53.36
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$33 - $53
Analyst target range
Wall Street analyst coverage for CSX is active, with six analysts providing estimates. The consensus estimates an average EPS of $2.69 for the upcoming period, with a range from $2.64 to $2.75. Revenue is estimated to average $17.47 billion. Recent institutional ratings show a mix of 'Buy', 'Overweight', and 'Market Perform' actions, indicating generally positive but cautious sentiment.
Bulls vs Bears: CSX Investment Factors
CSX demonstrates operational excellence and strong cash generation, driving significant market outperformance. However, recent softness in top-line growth and margins, coupled with a leveraged balance sheet and high valuation, present near-term headwinds. The stock's future hinges on its ability to reignite volume and earnings growth.
Bullish
- Strong Relative Performance: Outperformed S&P 500 by ~24% over the past year, showing resilience.
- Robust Profitability & Cash Flow: High net margin of 20.5% and strong $3.94B TTM free cash flow.
- Efficient Operations: Superior ROE of 22.0% and ROA of 6.9% indicate effective management.
- Analyst EPS Growth Expected: Forward P/E of 19.1 suggests market anticipates earnings growth.
Bearish
- Recent Revenue & Margin Pressure: Q4 revenue declined 0.9% YoY; net margin fell from 23.9% in Q2.
- High Valuation Multiples: Trailing P/E of 23.4 and P/S of 4.8 are elevated without peer context.
- Leveraged Balance Sheet: Debt-to-equity of 1.47 and current ratio of 0.81 indicate financial risk.
- Economic Sensitivity: Beta of 1.26 and cyclical freight mix make it vulnerable to downturns.
CSX Technical Analysis
The stock has demonstrated strong overall performance, rising 36.62% over the past year and significantly outperforming the broader market. Over the most recent three months, the stock gained 9.20%, contrasting sharply with the S&P 500's decline of 7.32%. However, the stock declined 6.84% over the past month, though it still showed relative strength compared to the market's 7.87% drop. In the short term, the stock price has retreated from its recent peak of $43.17 on March 2, 2026, to a current price of $39.77. The provided price data shows a clear uptrend from October 2025 through late February 2026, followed by a recent consolidation and pullback phase. The current price of $39.77 sits near the upper end of its 52-week range of $26.22 to $43.35, approximately 8.3% below the yearly high. The stock's beta of 1.26 indicates it is more volatile than the overall market.
Beta
1.26
1.26x market volatility
Max Drawdown
-16.8%
Largest decline past year
52-Week Range
$26-$43
Price range past year
Annual Return
+39.5%
Cumulative gain past year
| Period | CSX Return | S&P 500 |
|---|---|---|
| 1m | -3.8% | -5.3% |
| 3m | +13.2% | -4.6% |
| 6m | +15.4% | -2.8% |
| 1y | +39.5% | +15.9% |
| ytd | +13.2% | -4.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CSX Fundamental Analysis
Revenue for Q4 2025 was $3.51 billion, showing a slight year-over-year decline of 0.88% from the same quarter in 2024. Profitability remains robust, with a net margin of 20.5% for the quarter, though this is down from the 23.9% net margin reported in Q2 2025, indicating some recent pressure on earnings. The company's financial health is characterized by a debt-to-equity ratio of 1.47, indicating a leveraged balance sheet. However, it generates substantial cash flow, with free cash flow over the trailing twelve months reported at $3.94 billion, providing ample coverage for its obligations and shareholder returns. Operational efficiency is strong, as evidenced by a Return on Equity (ROE) of 21.95% and a Return on Assets (ROA) of 6.86%. The current ratio of 0.81 suggests a relatively tight liquidity position, which is typical for capital-intensive railroads.
Quarterly Revenue
$3.5B
2025-12
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
+0.31%
Latest Quarter
Free Cash Flow
$3.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CSX Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio is 23.39, while the forward P/E is 19.06 based on analyst estimates. This forward multiple suggests the market is pricing in expected earnings growth. Other valuation metrics include a Price-to-Sales (P/S) ratio of 4.79 and an Enterprise Value-to-EBITDA (EV/EBITDA) ratio of 14.70. No industry average comparison data was provided in the valuation inputs for peer benchmarking.
PE
23.4x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 13x~26x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.7x
Enterprise Value Multiple
Investment Risk Disclosure
CSX faces several key risks. Financially, the company operates with significant leverage (Debt/Equity of 1.47) and tight liquidity (Current Ratio of 0.81), which could constrain flexibility in a downturn. Operationally, the recent year-over-year decline in Q4 revenue and a sequential drop in net margin from 23.9% to 20.5% signal potential volume weakness or pricing pressure in its core freight segments like coal, chemicals, and intermodal. Market risks are pronounced given the stock's beta of 1.26, making it more volatile than the broader market, and its current price near the upper end of its 52-week range leaves limited margin for error. Furthermore, the lack of recent news suggests no immediate positive catalysts to counter these fundamental concerns.
FAQ
Key risks include economic sensitivity (beta of 1.26), a leveraged balance sheet (debt-to-equity of 1.47), and recent fundamental softness with declining Q4 revenue and net margins. The stock is also trading near its 52-week high, which could lead to volatility if growth disappoints. Its reliance on cyclical freight like coal and chemicals adds to macroeconomic risk.
The 12-month outlook is neutral with a base case target range of $38 to $43. This is based on the company meeting analyst EPS estimates of $2.69 and maintaining a forward P/E near 19x. A bull case (25% probability) could see a retest of the 52-week high of $43.35 and beyond, while a bear case (15% probability) could see a pullback towards the $30-$35 range if the economy weakens.
CSX appears fairly valued to slightly overvalued based on current data. Its trailing P/E of 23.4 and Price/Sales of 4.79 are not cheap, though the forward P/E of 19.1 suggests the market is pricing in expected EPS growth to $2.69. Without a clear acceleration in growth, the current multiples leave little room for error, indicating the stock is not demonstrably undervalued.
CSX is a Hold at current levels. It is a fundamentally strong company with a 22% ROE and $3.94B in annual free cash flow. However, its trailing P/E of 23.4 is elevated, and recent quarterly revenue declined 0.9% year-over-year, suggesting the stock is fairly valued with limited near-term catalysts. A more attractive buying opportunity may arise on a larger pullback.
CSX is more suitable for a long-term investment horizon. Its competitive moat, efficient network, and strong cash flows support durable value creation over time. For short-term traders, the stock's high beta of 1.26 and recent volatility present opportunities but also significant risk, especially given the lack of immediate positive catalysts to drive the price higher from current levels.